Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of eithe...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Behringer, Karolin [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Effects of shape functions on flexural–torsional buckling of fixed circular arches - Dou, Chao ELSEVIER, 2013, London [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:385 ; year:2015 ; number:9976 ; day:11 ; month:04 ; pages:1418-1427 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0140-6736(14)61469-0 |
|---|
| Katalog-ID: |
ELV03433792X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV03433792X | ||
| 003 | DE-627 | ||
| 005 | 20230624012825.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(14)61469-0 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015002000012.pica |
| 035 | |a (DE-627)ELV03433792X | ||
| 035 | |a (ELSEVIER)S0140-6736(14)61469-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 690 |q VZ |
| 084 | |a 38.38 |2 bkl | ||
| 084 | |a 56.20 |2 bkl | ||
| 084 | |a 56.11 |2 bkl | ||
| 100 | 1 | |a Behringer, Karolin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial |
| 264 | 1 | |c 2015 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. | ||
| 700 | 1 | |a Goergen, Helen |4 oth | |
| 700 | 1 | |a Hitz, Felicitas |4 oth | |
| 700 | 1 | |a Zijlstra, Josée M |4 oth | |
| 700 | 1 | |a Greil, Richard |4 oth | |
| 700 | 1 | |a Markova, Jana |4 oth | |
| 700 | 1 | |a Sasse, Stephanie |4 oth | |
| 700 | 1 | |a Fuchs, Michael |4 oth | |
| 700 | 1 | |a Topp, Max S |4 oth | |
| 700 | 1 | |a Soekler, Martin |4 oth | |
| 700 | 1 | |a Mathas, Stephan |4 oth | |
| 700 | 1 | |a Meissner, Julia |4 oth | |
| 700 | 1 | |a Wilhelm, Martin |4 oth | |
| 700 | 1 | |a Koch, Peter |4 oth | |
| 700 | 1 | |a Lindemann, Hans-Walter |4 oth | |
| 700 | 1 | |a Schalk, Enrico |4 oth | |
| 700 | 1 | |a Semrau, Robert |4 oth | |
| 700 | 1 | |a Kriz, Jan |4 oth | |
| 700 | 1 | |a Vieler, Tom |4 oth | |
| 700 | 1 | |a Bentz, Martin |4 oth | |
| 700 | 1 | |a Lange, Elisabeth |4 oth | |
| 700 | 1 | |a Mahlberg, Rolf |4 oth | |
| 700 | 1 | |a Hassler, Andre |4 oth | |
| 700 | 1 | |a Vogelhuber, Martin |4 oth | |
| 700 | 1 | |a Hahn, Dennis |4 oth | |
| 700 | 1 | |a Mezger, Jörg |4 oth | |
| 700 | 1 | |a Krause, Stefan W |4 oth | |
| 700 | 1 | |a Skoetz, Nicole |4 oth | |
| 700 | 1 | |a Böll, Boris |4 oth | |
| 700 | 1 | |a von Tresckow, Bastian |4 oth | |
| 700 | 1 | |a Diehl, Volker |4 oth | |
| 700 | 1 | |a Hallek, Michael |4 oth | |
| 700 | 1 | |a Borchmann, Peter |4 oth | |
| 700 | 1 | |a Stein, Harald |4 oth | |
| 700 | 1 | |a Eich, Hans |4 oth | |
| 700 | 1 | |a Engert, Andreas |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Dou, Chao ELSEVIER |t Effects of shape functions on flexural–torsional buckling of fixed circular arches |d 2013 |g London [u.a.] |w (DE-627)ELV007685041 |
| 773 | 1 | 8 | |g volume:385 |g year:2015 |g number:9976 |g day:11 |g month:04 |g pages:1418-1427 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0140-6736(14)61469-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-GEO | ||
| 936 | b | k | |a 38.38 |j Seismologie |q VZ |
| 936 | b | k | |a 56.20 |j Ingenieurgeologie |j Bodenmechanik |q VZ |
| 936 | b | k | |a 56.11 |j Baukonstruktion |q VZ |
| 951 | |a AR | ||
| 952 | |d 385 |j 2015 |e 9976 |b 11 |c 0411 |h 1418-1427 |g 10 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
k b kb |
|---|---|
| matchkey_str |
behringerkarolingoergenhelenhitzfelicita:2015----:msinfaabznobemcnrohrmhavrgmnnramnoerytgfvualhdknlmhmgsh1a |
| hierarchy_sort_str |
2015 |
| bklnumber |
38.38 56.20 56.11 |
| publishDate |
2015 |
| allfields |
10.1016/S0140-6736(14)61469-0 doi GBVA2015002000012.pica (DE-627)ELV03433792X (ELSEVIER)S0140-6736(14)61469-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Behringer, Karolin verfasserin aut Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. Goergen, Helen oth Hitz, Felicitas oth Zijlstra, Josée M oth Greil, Richard oth Markova, Jana oth Sasse, Stephanie oth Fuchs, Michael oth Topp, Max S oth Soekler, Martin oth Mathas, Stephan oth Meissner, Julia oth Wilhelm, Martin oth Koch, Peter oth Lindemann, Hans-Walter oth Schalk, Enrico oth Semrau, Robert oth Kriz, Jan oth Vieler, Tom oth Bentz, Martin oth Lange, Elisabeth oth Mahlberg, Rolf oth Hassler, Andre oth Vogelhuber, Martin oth Hahn, Dennis oth Mezger, Jörg oth Krause, Stefan W oth Skoetz, Nicole oth Böll, Boris oth von Tresckow, Bastian oth Diehl, Volker oth Hallek, Michael oth Borchmann, Peter oth Stein, Harald oth Eich, Hans oth Engert, Andreas oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:385 year:2015 number:9976 day:11 month:04 pages:1418-1427 extent:10 https://doi.org/10.1016/S0140-6736(14)61469-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 385 2015 9976 11 0411 1418-1427 10 045F 610 |
| spelling |
10.1016/S0140-6736(14)61469-0 doi GBVA2015002000012.pica (DE-627)ELV03433792X (ELSEVIER)S0140-6736(14)61469-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Behringer, Karolin verfasserin aut Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. Goergen, Helen oth Hitz, Felicitas oth Zijlstra, Josée M oth Greil, Richard oth Markova, Jana oth Sasse, Stephanie oth Fuchs, Michael oth Topp, Max S oth Soekler, Martin oth Mathas, Stephan oth Meissner, Julia oth Wilhelm, Martin oth Koch, Peter oth Lindemann, Hans-Walter oth Schalk, Enrico oth Semrau, Robert oth Kriz, Jan oth Vieler, Tom oth Bentz, Martin oth Lange, Elisabeth oth Mahlberg, Rolf oth Hassler, Andre oth Vogelhuber, Martin oth Hahn, Dennis oth Mezger, Jörg oth Krause, Stefan W oth Skoetz, Nicole oth Böll, Boris oth von Tresckow, Bastian oth Diehl, Volker oth Hallek, Michael oth Borchmann, Peter oth Stein, Harald oth Eich, Hans oth Engert, Andreas oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:385 year:2015 number:9976 day:11 month:04 pages:1418-1427 extent:10 https://doi.org/10.1016/S0140-6736(14)61469-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 385 2015 9976 11 0411 1418-1427 10 045F 610 |
| allfields_unstemmed |
10.1016/S0140-6736(14)61469-0 doi GBVA2015002000012.pica (DE-627)ELV03433792X (ELSEVIER)S0140-6736(14)61469-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Behringer, Karolin verfasserin aut Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. Goergen, Helen oth Hitz, Felicitas oth Zijlstra, Josée M oth Greil, Richard oth Markova, Jana oth Sasse, Stephanie oth Fuchs, Michael oth Topp, Max S oth Soekler, Martin oth Mathas, Stephan oth Meissner, Julia oth Wilhelm, Martin oth Koch, Peter oth Lindemann, Hans-Walter oth Schalk, Enrico oth Semrau, Robert oth Kriz, Jan oth Vieler, Tom oth Bentz, Martin oth Lange, Elisabeth oth Mahlberg, Rolf oth Hassler, Andre oth Vogelhuber, Martin oth Hahn, Dennis oth Mezger, Jörg oth Krause, Stefan W oth Skoetz, Nicole oth Böll, Boris oth von Tresckow, Bastian oth Diehl, Volker oth Hallek, Michael oth Borchmann, Peter oth Stein, Harald oth Eich, Hans oth Engert, Andreas oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:385 year:2015 number:9976 day:11 month:04 pages:1418-1427 extent:10 https://doi.org/10.1016/S0140-6736(14)61469-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 385 2015 9976 11 0411 1418-1427 10 045F 610 |
| allfieldsGer |
10.1016/S0140-6736(14)61469-0 doi GBVA2015002000012.pica (DE-627)ELV03433792X (ELSEVIER)S0140-6736(14)61469-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Behringer, Karolin verfasserin aut Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. Goergen, Helen oth Hitz, Felicitas oth Zijlstra, Josée M oth Greil, Richard oth Markova, Jana oth Sasse, Stephanie oth Fuchs, Michael oth Topp, Max S oth Soekler, Martin oth Mathas, Stephan oth Meissner, Julia oth Wilhelm, Martin oth Koch, Peter oth Lindemann, Hans-Walter oth Schalk, Enrico oth Semrau, Robert oth Kriz, Jan oth Vieler, Tom oth Bentz, Martin oth Lange, Elisabeth oth Mahlberg, Rolf oth Hassler, Andre oth Vogelhuber, Martin oth Hahn, Dennis oth Mezger, Jörg oth Krause, Stefan W oth Skoetz, Nicole oth Böll, Boris oth von Tresckow, Bastian oth Diehl, Volker oth Hallek, Michael oth Borchmann, Peter oth Stein, Harald oth Eich, Hans oth Engert, Andreas oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:385 year:2015 number:9976 day:11 month:04 pages:1418-1427 extent:10 https://doi.org/10.1016/S0140-6736(14)61469-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 385 2015 9976 11 0411 1418-1427 10 045F 610 |
| allfieldsSound |
10.1016/S0140-6736(14)61469-0 doi GBVA2015002000012.pica (DE-627)ELV03433792X (ELSEVIER)S0140-6736(14)61469-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Behringer, Karolin verfasserin aut Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial 2015 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. Goergen, Helen oth Hitz, Felicitas oth Zijlstra, Josée M oth Greil, Richard oth Markova, Jana oth Sasse, Stephanie oth Fuchs, Michael oth Topp, Max S oth Soekler, Martin oth Mathas, Stephan oth Meissner, Julia oth Wilhelm, Martin oth Koch, Peter oth Lindemann, Hans-Walter oth Schalk, Enrico oth Semrau, Robert oth Kriz, Jan oth Vieler, Tom oth Bentz, Martin oth Lange, Elisabeth oth Mahlberg, Rolf oth Hassler, Andre oth Vogelhuber, Martin oth Hahn, Dennis oth Mezger, Jörg oth Krause, Stefan W oth Skoetz, Nicole oth Böll, Boris oth von Tresckow, Bastian oth Diehl, Volker oth Hallek, Michael oth Borchmann, Peter oth Stein, Harald oth Eich, Hans oth Engert, Andreas oth Enthalten in Elsevier Dou, Chao ELSEVIER Effects of shape functions on flexural–torsional buckling of fixed circular arches 2013 London [u.a.] (DE-627)ELV007685041 volume:385 year:2015 number:9976 day:11 month:04 pages:1418-1427 extent:10 https://doi.org/10.1016/S0140-6736(14)61469-0 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO 38.38 Seismologie VZ 56.20 Ingenieurgeologie Bodenmechanik VZ 56.11 Baukonstruktion VZ AR 385 2015 9976 11 0411 1418-1427 10 045F 610 |
| language |
English |
| source |
Enthalten in Effects of shape functions on flexural–torsional buckling of fixed circular arches London [u.a.] volume:385 year:2015 number:9976 day:11 month:04 pages:1418-1427 extent:10 |
| sourceStr |
Enthalten in Effects of shape functions on flexural–torsional buckling of fixed circular arches London [u.a.] volume:385 year:2015 number:9976 day:11 month:04 pages:1418-1427 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Seismologie Ingenieurgeologie Bodenmechanik Baukonstruktion |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| authorswithroles_txt_mv |
Behringer, Karolin @@aut@@ Goergen, Helen @@oth@@ Hitz, Felicitas @@oth@@ Zijlstra, Josée M @@oth@@ Greil, Richard @@oth@@ Markova, Jana @@oth@@ Sasse, Stephanie @@oth@@ Fuchs, Michael @@oth@@ Topp, Max S @@oth@@ Soekler, Martin @@oth@@ Mathas, Stephan @@oth@@ Meissner, Julia @@oth@@ Wilhelm, Martin @@oth@@ Koch, Peter @@oth@@ Lindemann, Hans-Walter @@oth@@ Schalk, Enrico @@oth@@ Semrau, Robert @@oth@@ Kriz, Jan @@oth@@ Vieler, Tom @@oth@@ Bentz, Martin @@oth@@ Lange, Elisabeth @@oth@@ Mahlberg, Rolf @@oth@@ Hassler, Andre @@oth@@ Vogelhuber, Martin @@oth@@ Hahn, Dennis @@oth@@ Mezger, Jörg @@oth@@ Krause, Stefan W @@oth@@ Skoetz, Nicole @@oth@@ Böll, Boris @@oth@@ von Tresckow, Bastian @@oth@@ Diehl, Volker @@oth@@ Hallek, Michael @@oth@@ Borchmann, Peter @@oth@@ Stein, Harald @@oth@@ Eich, Hans @@oth@@ Engert, Andreas @@oth@@ |
| publishDateDaySort_date |
2015-01-11T00:00:00Z |
| hierarchy_top_id |
ELV007685041 |
| dewey-sort |
3610 |
| id |
ELV03433792X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03433792X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624012825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0140-6736(14)61469-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015002000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03433792X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0140-6736(14)61469-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Behringer, Karolin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goergen, Helen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hitz, Felicitas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zijlstra, Josée M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Greil, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Markova, Jana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sasse, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fuchs, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Topp, Max S</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soekler, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mathas, Stephan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meissner, Julia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wilhelm, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koch, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lindemann, Hans-Walter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schalk, Enrico</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Semrau, Robert</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kriz, Jan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vieler, Tom</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bentz, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lange, Elisabeth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahlberg, Rolf</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hassler, Andre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vogelhuber, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hahn, Dennis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mezger, Jörg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krause, Stefan W</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Skoetz, Nicole</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Böll, Boris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Tresckow, Bastian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Diehl, Volker</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hallek, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Borchmann, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stein, Harald</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eich, Hans</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engert, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dou, Chao ELSEVIER</subfield><subfield code="t">Effects of shape functions on flexural–torsional buckling of fixed circular arches</subfield><subfield code="d">2013</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV007685041</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:385</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:9976</subfield><subfield code="g">day:11</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:1418-1427</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0140-6736(14)61469-0</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.38</subfield><subfield code="j">Seismologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.20</subfield><subfield code="j">Ingenieurgeologie</subfield><subfield code="j">Bodenmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.11</subfield><subfield code="j">Baukonstruktion</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">385</subfield><subfield code="j">2015</subfield><subfield code="e">9976</subfield><subfield code="b">11</subfield><subfield code="c">0411</subfield><subfield code="h">1418-1427</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Behringer, Karolin |
| spellingShingle |
Behringer, Karolin ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial |
| authorStr |
Behringer, Karolin |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007685041 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 690 - Buildings |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial |
| topic |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| topic_unstemmed |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| topic_browse |
ddc 610 ddc 690 bkl 38.38 bkl 56.20 bkl 56.11 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h g hg f h fh j m z jm jmz r g rg j m jm s s ss m f mf m s t ms mst m s ms s m sm j m jm m w mw p k pk h w l hwl e s es r s rs j k jk t v tv m b mb e l el r m rm a h ah m v mv d h dh j m jm s w k sw swk n s ns b b bb t b v tb tbv v d vd m h mh p b pb h s hs h e he a e ae |
| hierarchy_parent_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| hierarchy_parent_id |
ELV007685041 |
| dewey-tens |
610 - Medicine & health 690 - Building & construction |
| hierarchy_top_title |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007685041 |
| title |
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial |
| ctrlnum |
(DE-627)ELV03433792X (ELSEVIER)S0140-6736(14)61469-0 |
| title_full |
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial |
| author_sort |
Behringer, Karolin |
| journal |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| journalStr |
Effects of shape functions on flexural–torsional buckling of fixed circular arches |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
1418 |
| author_browse |
Behringer, Karolin |
| container_volume |
385 |
| physical |
10 |
| class |
610 610 DE-600 690 VZ 38.38 bkl 56.20 bkl 56.11 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Behringer, Karolin |
| doi_str_mv |
10.1016/S0140-6736(14)61469-0 |
| dewey-full |
610 690 |
| title_sort |
omission of dacarbazine or bleomycin, or both, from the abvd regimen in treatment of early-stage favourable hodgkin's lymphoma (ghsg hd13): an open-label, randomised, non-inferiority trial |
| title_auth |
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial |
| abstract |
The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. |
| abstractGer |
The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. |
| abstract_unstemmed |
The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GEO |
| container_issue |
9976 |
| title_short |
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial |
| url |
https://doi.org/10.1016/S0140-6736(14)61469-0 |
| remote_bool |
true |
| author2 |
Goergen, Helen Hitz, Felicitas Zijlstra, Josée M Greil, Richard Markova, Jana Sasse, Stephanie Fuchs, Michael Topp, Max S Soekler, Martin Mathas, Stephan Meissner, Julia Wilhelm, Martin Koch, Peter Lindemann, Hans-Walter Schalk, Enrico Semrau, Robert Kriz, Jan Vieler, Tom Bentz, Martin Lange, Elisabeth Mahlberg, Rolf Hassler, Andre Vogelhuber, Martin Hahn, Dennis Mezger, Jörg Krause, Stefan W Skoetz, Nicole Böll, Boris von Tresckow, Bastian Diehl, Volker Hallek, Michael Borchmann, Peter Stein, Harald Eich, Hans Engert, Andreas |
| author2Str |
Goergen, Helen Hitz, Felicitas Zijlstra, Josée M Greil, Richard Markova, Jana Sasse, Stephanie Fuchs, Michael Topp, Max S Soekler, Martin Mathas, Stephan Meissner, Julia Wilhelm, Martin Koch, Peter Lindemann, Hans-Walter Schalk, Enrico Semrau, Robert Kriz, Jan Vieler, Tom Bentz, Martin Lange, Elisabeth Mahlberg, Rolf Hassler, Andre Vogelhuber, Martin Hahn, Dennis Mezger, Jörg Krause, Stefan W Skoetz, Nicole Böll, Boris von Tresckow, Bastian Diehl, Volker Hallek, Michael Borchmann, Peter Stein, Harald Eich, Hans Engert, Andreas |
| ppnlink |
ELV007685041 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0140-6736(14)61469-0 |
| up_date |
2024-07-06T20:52:44.247Z |
| _version_ |
1803864416451559424 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03433792X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624012825.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0140-6736(14)61469-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015002000012.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03433792X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0140-6736(14)61469-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">38.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">56.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Behringer, Karolin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goergen, Helen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hitz, Felicitas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zijlstra, Josée M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Greil, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Markova, Jana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sasse, Stephanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fuchs, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Topp, Max S</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soekler, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mathas, Stephan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meissner, Julia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wilhelm, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koch, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lindemann, Hans-Walter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schalk, Enrico</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Semrau, Robert</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kriz, Jan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vieler, Tom</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bentz, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lange, Elisabeth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahlberg, Rolf</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hassler, Andre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vogelhuber, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hahn, Dennis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mezger, Jörg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krause, Stefan W</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Skoetz, Nicole</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Böll, Boris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Tresckow, Bastian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Diehl, Volker</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hallek, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Borchmann, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stein, Harald</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eich, Hans</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engert, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dou, Chao ELSEVIER</subfield><subfield code="t">Effects of shape functions on flexural–torsional buckling of fixed circular arches</subfield><subfield code="d">2013</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV007685041</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:385</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:9976</subfield><subfield code="g">day:11</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:1418-1427</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0140-6736(14)61469-0</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GEO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">38.38</subfield><subfield code="j">Seismologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.20</subfield><subfield code="j">Ingenieurgeologie</subfield><subfield code="j">Bodenmechanik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">56.11</subfield><subfield code="j">Baukonstruktion</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">385</subfield><subfield code="j">2015</subfield><subfield code="e">9976</subfield><subfield code="b">11</subfield><subfield code="c">0411</subfield><subfield code="h">1418-1427</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4010687 |